Granite FO LLC

Position in NVS — Novartis AG

CIK 2034090 BEDFORD, NH

Position in NVS

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$2,194

+$56 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,589

of 1,603 holders

Holding Since

Mar 2024

9 quarters on record

Healthcare · as of Jun 30, 2026

Granite FO LLC holds $2,135,472 across 7 Drug Manufacturers - General names. NVS ranks #7 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,000	$1,199,428
2	PFE	Pfizer Inc	21,303	$512,976
3	JNJ	Johnson & Johnson	1,356	$344,383
4	MRK	Merck & Co., Inc.	347	$44,588
5	NVO	Novo Nordisk A S	590	$28,282
6	AMGN	Amgen Inc	10	$3,621
7	NVS	Novartis AG This page	14	$2,194

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,194	14	0.0%	Shares	Sole	2026-07-15
2026-03-31	$2,138	14	0.0%	Shares	Sole	2026-05-12
2025-12-31	$1,930	14	0.0%	Shares	Sole	2026-02-06
2025-09-30	$1,795	14	0.0%	Shares	Sole	2025-10-22
2025-06-30	$1,694	14	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,560	14	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,362	14	0.0%	Shares	Sole	2025-02-06
2024-09-30	$1,610	14	0.0%	Shares	Sole	2024-10-18
2024-03-31	$1,354	14	—	Shares	Sole	2024-09-05
No filing history on record for this holder in this stock.